πŸ‡ΊπŸ‡Έ FDA
Patent

US 8383647

Quinoline derivative

granted A61PA61P15/10A61P17/00

Quick answer

US patent 8383647 (Quinoline derivative) held by Takeda Pharmaceutical Company Limited expires Mon Feb 21 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Takeda Pharmaceutical Company Limited
Grant date
Tue Feb 26 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 21 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
18
CPC classes
A61P, A61P15/10, A61P17/00, A61P19/02, A61P25/00